PCD Pharma Franchise Opportunities in Chandigarh with Daksh Diabetes and Cardiac Care
Recent data from the National Family Health Survey (NFHS-6) 2023-24 paints a stark picture of Chandigarh’s escalating metabolic crisis. The survey reveals that 48.5% of adult men are now overweight or obese, marking a sharp rise from 34.4% in NFHS-5 and nearly double the national average of 27.3%. Among women, 41.9% are overweight or obese, significantly higher than the national average of 30.7%.
This obesity crisis is directly fueling Chandigarh’s reputation as a diabetes hotspot. The survey found that 17.1% of men and 17.8% of women have high blood sugar levels or are on diabetes medication. Specifically, 10% of women and 9.8% of men recorded very high blood sugar levels above 160 mg/dl. An ICMR study has confirmed that nearly one in four Chandigarh residents suffers from diabetes or prediabetes.
The burden of hypertension adds another layer of concern. NFHS-6 shows that 24.4% of men and 22.4% of women have elevated blood pressure. Alarmingly, 40% of registered NCD patients reported a positive family history, and experts note that obesity acts as the ultimate catalyst your DNA dictates whether it triggers diabetes or hypertension first. Noncommunicable diseases (NCDs) like cancer, heart attacks, and strokes already account for nearly 75% of all deaths in Chandigarh.
The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Chandigarh families through regular screening, medication adherence, lifestyle modifications, and early detection ensuring thousands become success stories of integrated care and better health outcomes.
How Daksh is making a Difference in Chandigarh
1. Affordable, Quality-Assured Medications
Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment.
What this means for Chandigarh patients:
- Access to WHO-GMP certified medications
- Lower out-of-pocket expenses for lifelong treatments
- No compromise on quality despite affordable pricing
2. Complete Cardiac Care Portfolio
Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs:
| Product Category | Daksh Offerings | Purpose |
| ACE Inhibitors | DORAPIL (Ramipril) | Blood pressure control, heart failure treatment |
| ARBs | CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) | Hypertension management |
| Beta-Blockers | CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) | Heart rate control, heart failure |
| Calcium Channel Blockers | DUPIN (Amlodipine), CLINITAC (Cilnidipine) | Blood pressure, angina |
| Diuretics | TORDAC (Torsemide), FRUSIDIP | Fluid management in heart failure |
| Lipid Management | ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) | Cholesterol control |
3. Complete Diabetic Care Portfolio
For diabetes management, Daksh provides modern therapeutic options including:
| Product Category | Daksh Offerings |
| SGLT2 Inhibitors | DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug |
| DPP-4 Inhibitors | TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) |
| Sulfonylureas | GLIMIDAC (Glimepiride) |
| Biguanides | GLYCODIP SR (Metformin) |
| Combination Therapies | DYFOZIN M, GLIMIDAC MV (triple combination) |
4. Focus on Preventive Care
Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications:
- Liver tonics for medication-induced liver protection
- Calcium supplements for bone health (critical for diabetic patients)
- Vitamin complexes for overall metabolic support
5. Supporting Healthcare Providers across Chandigarh
Daksh works with hospitals, clinics, and pharmacies across Chandigarh and its Tricity area (Mohali, Panchkula) to ensure that quality medications reach every corner. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses.
The diabetes and heart disease epidemic in Chandigarh is not just a statistic it is a reality affecting thousands of families. With the city recording a 48.5% male obesity rate, a 17.1% diabetes prevalence among men, and hypertension affecting nearly a quarter of adults, the burden is already immense and growing. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives.
With the city’s low initial investment requirements and monopoly rights in selected territories, there is immense potential to build a meaningful healthcare business while serving your community.
Conclusion
Daksh Diabetic & Cardiac Care is committed to being part of this solution providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines.
Contact Daksh Diabetic and Cardiac
| Contact Method | Details | |
| Office Address | Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India | |
| Phone | 📞 +91 93565 60523 📞 +91 78886 02869 | |
| enquirypurchase.daksh@gmail.com | ||
| Contact us | https://diabetes-cardiac.com/contact-us/ |